Discover
CTXR
Citius Pharmaceuticals, Inc.
0.50
2 x 0.38
2 x 0.69
bid
ask
+
0.01
2.19%
2 @ 04:18 PM
0.50 +0.00 (0.12%)
| Ytd | -35.73% | |
| 1y | -60.98% |
0.48
day range
0.51
0.48
52 week range
1.82
| Open | 0.49 | Prev Close | 0.49 | Low | 0.48 | High | 0.51 | Mkt Cap | 13.71M |
| Vol | 144.28K | Avg Vol | 527.79K | EPS | -1.76 | P/E | N/A | Forward P/E | 15.32 |
| Beta | 1.66 | Short Ratio | 1.23 | Inst. Own | 13.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.60 | 200-d Avg | 0.69 | 1yr Est | 54.00 |
| Income Statement | |||
| Total Revenue | 1.49M | ||
| Revenues (USD) | 1.49M | ||
| Cost of Revenue | 491.84K | ||
| Gross Profit | 1.00M | ||
| Operating Expenses | 12.73M | ||
| Research and Development Expense | 1.05M | ||
| Selling, General and Administrative Expense | 6.15M | ||
| Operating Income | -11.73M | ||
| Interest Expense | 231.73K | ||
| Income Tax Expense | -107.35K | ||
| Net Income | -8.86M | ||
| Net Income Common Stock | -8.86M | ||
| Net Income Common Stock (USD) | -8.86M | ||
| Consolidated Income | -11.92M | ||
| Net Income to Non-Controlling Interests | -3.06M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -8.74M | ||
| Earning Before Interest & Taxes (USD) | -8.74M | ||
| Weighted Average Shares | 26.17M | ||
| Weighted Average Shares Diluted | 26.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.05M | ||
| Cash and Equivalents (USD) | 17.05M | ||
| Trade and Non-Trade Receivables | 686.24K | ||
| Current Assets | 43.33M | ||
| Property, Plant & Equipment Net | 753.04K | ||
| Total Assets | 142.26M | ||
| Debt Current | 176.17K | ||
| Total Debt | 7.18M | ||
| Current Liabilities | 51.65M | ||
| Debt Non-Current | 7.00M | ||
| Total Liabilities | 66.35M | ||
| Accumulated Retained Earnings (Deficit) | -277.12M | ||
| Shareholders Equity | 66.61M | ||
| Shareholders Equity (USD) | 66.61M | ||
| Assets Non-Current | 98.92M | ||
| Total Debt (USD) | 7.18M | ||
| Goodwill and Intangible Assets | 9.35M | ||
| Inventory | 22.63M | ||
| Liabilities Non-Current | 14.70M | ||
| Trade and Non-Trade Payables | 23.69M | ||
| Tax Liabilities | 7.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 41.48K | ||
| Net Cash Flow from Financing | 23.09M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.42M | ||
| Capital Expenditure | -2.00M | ||
| Issuance (Purchase) of Equity Shares | 14.18M | ||
| Issuance (Repayment) of Debt Securities | 9.64M | ||
| Net Cash Flow from Investing | -2.00M | ||
| Net Cash Flow from Operations | -8.68M | ||
| Share Based Compensation | 3.81M | ||